- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02810496
Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia (MUTA-GR)
June 20, 2016 updated by: CHU de Reims
Prevalence of Mutations of Glucocorticoid Receptors in Bilateral Adrenal Hyperplasia
As the investigators observed a case of glucocorticoid mutation revealed by incidentally discovered bilateral adrenal nodular hyperplasia, it was postulated that this molecular anormality could be more frequent than previously described.
To validate this hypothesis, it was decided to study 150 multicenter consecutive patients, presenting with incidentally discovered bilateral adrenal masses without clinical signs of Cushing's disease.
In all these patients GR gene will be studied, mutations will be detected and described, functional disturbance will be tested.
Usual polymorphisms will be described.
Correlation between clinical signs, hormonal and morphological abnormalities and presence or absence of GR mutations will be searched.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brigitte DELEMER
- Phone Number: 326788101
- Email: bdelemer@chu-reims.fr
Study Locations
-
-
Reims
-
France, Reims, France, 51092
- Recruiting
- CHU Reims
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients more than 18 years of age
- patients with bilateral adrenal masses
Exclusion Criteria:
- Refusing to participate in the study
- Protected by law
- Have obvious signs of Cushing's syndrome
- No progressive neoplastic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: patient
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
frequency of mutations
Time Frame: DAY 0
|
DAY 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
June 16, 2016
First Submitted That Met QC Criteria
June 20, 2016
First Posted (Estimate)
June 23, 2016
Study Record Updates
Last Update Posted (Estimate)
June 23, 2016
Last Update Submitted That Met QC Criteria
June 20, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Metabolic Diseases
- Endocrine System Diseases
- Gonadal Disorders
- Disorders of Sex Development
- Urogenital Abnormalities
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Metabolism, Inborn Errors
- Adrenal Gland Diseases
- Steroid Metabolism, Inborn Errors
- Hyperplasia
- Adrenal Hyperplasia, Congenital
- Adrenogenital Syndrome
Other Study ID Numbers
- PN11010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on General Glucocorticoid Resistance
-
Eunice Kennedy Shriver National Institute of Child...CompletedACTH | Glucocorticoid | Cortisol Resistance | Negative Feedback | MineralcorticoidUnited States
-
Rambam Health Care CampusUnknown
-
University Hospital, Basel, SwitzerlandCompletedPatients With Glucocorticoid TreatmentSwitzerland
-
AmgenCompletedSteroid-induced Osteopor, Glucocorticoid-induced OsteporDenmark, Netherlands, Belgium, United States, Czechia, Poland, Russian Federation, Hungary, Korea, Republic of, Spain, Germany, France, Canada, Argentina, Colombia, Mexico
-
Amsterdam UMC, location VUmcNational Research Council, Institute of Biomedical EngineeringCompletedGlucocorticoid-induced Glucometabolic Abnormalities | Glucocorticoid-induced Beta-cell DysfunctionNetherlands
-
Eleonora SeeligCompletedGlucocorticoid EffectSwitzerland
-
Eleonora SeeligCompletedGlucocorticoid EffectSwitzerland
-
Tianjin Medical UniversityPeking University First Hospital; Peking Union Medical College Hospital; Zhongshan...RecruitingUveitis | Metformin | GlucocorticoidChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingGlucocorticoid-Refractory aGVHDChina
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); AllerGen NCE Inc.RecruitingExposure to Pollution | Glucocorticoid ResistanceCanada
Clinical Trials on blood collection for mutation characterization
-
Centre Hospitalier Universitaire de la RéunionNot yet recruitingBreast Cancer | BRCA2 Mutation | Genetic Disease
-
Sir Run Run Shaw HospitalNot yet recruitingCatheter ComplicationsChina
-
Hans SmitRijnstate Hospital; Prof. Dr. Jaap Swieringa stichting; Mr. Willem Bakhuys RoozeboomstichtingUnknown
-
University of AberdeenRecruitingTakotsubo CardiomyopathyUnited Kingdom
-
Fondazione del Piemonte per l'OncologiaUnknownGastrointestinal Stromal Tumor (GIST)Italy
-
University of UtahDepartment of Health and Human ServicesCompletedLow Birth Weight | Immunodeficiency | Small for Gestational AgeUnited States
-
Gritstone bio, Inc.CompletedColorectal Cancer | Non Small Cell Lung Cancer | Gastroesophageal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Urothelial CarcinomaUnited States
-
Gritstone bio, Inc.CompletedMetastatic Colorectal Cancer | Stage II/III Colon CancerUnited States
-
Ela ShaiCompletedInherited Platelet DisordersIsrael
-
Indiana UniversityActive, not recruitingMelanoma; Renal Cell CarcinomaUnited States